UK-based company Epsilogen is even more confident in its claim to be a global leader in the development of novel immunoglobulin E (IgE) antibodies to treat canc 26 April 2023
USA-based company ImmunoGen, a specialist in the field of antibody-drug conjugates (ADCs) for the treatment of cancer, has appointed Isabel Kalofonos as senior 24 April 2023
Engimmune Therapeutics, a biotech developing novel T-cell receptor (TCR)-based therapies, has announced the appointment of Lars Nieba as chief executive. 19 April 2023
US biopharma Inozyme Pharma has announced that founding chief executive officer Axel Bolte will retire from his current role, to be replaced by Douglas Treco. 24 March 2023
Beam Therapeutics, a US biotech developing precision genetic medicines through base editing, has named Gopi Shanker its chief scientific officer (CSO). 22 March 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.